Our directors, director nominees and officers are as follows: Name ​ ​ Age ​ ​ Title ​ Brendan T. O’Donnell ​ ​ 33 ​ ​ Chief Executive Officer ​ Nicholas S. Schorsch, Jr. ​ ​ 35 ​ ​ President ​ Joseph Marnikovic ​ ​ 47 ​ ​ Chief Financial Officer and Treasurer ​ Michael R. Anderson ​ ​ 32 ​ ​ General Counsel and Secretary ​ Nicholas S. Schorsch ​ ​ 59 ​ ​ Chairman of the Board of Directors ​ Edward M. Weil, Jr. ​ ​ 53 ​ ​ Director Nominee ​ Leslie D. Michelson ​ ​ 69 ​ ​ Director Nominee ​ M. Therese Antone ​ ​ 81 ​ ​ Director Nominee ​ Nicholas Radesca ​ ​ 55 ​ ​ Director Nominee ​ Brendan T. O’Donnell has been our Chief Executive Officer since December 2020. Mr. O’Donnell has over twelve years of experience as an owner, operator and manager of hospitality and real estate companies. Since November 2017, he has been the Chief Executive Officer of Newport Craft, a rapidly expanding craft brewer and distiller with distribution that he has grown from local to nationwide. At Newport Craft, Mr. O’Donnell has led the acquisition and successful integration of Braven Brewing Company and Radiant Pig Beer Company, a modernization and expansion of Newport Craft’s production facility and sponsorship agreements with the New York Mets and EPCOT in Disney World. In addition, since November 2017, Mr. O’Donnell has been the manager of 1639 Ventures, LLC. Since January 2017, Mr. O’Donnell has also been the manager of the 1899 family of companies, which include a historic, full-service restaurant and catering business and a rapidly expanding fleet of food trucks. Mr. O’Donnell serves as the Director of Food and Beverage for The Newport Concours d’Elegance which is one of the premier motor weeks in the United States. He is also a partner and is currently an advisory board member for The Next Step Realty, a rental platform that is focused on apartment rentals for corporate relocations in the New York City, with over 150 corporate clients. From June 2015 until December 2016, Mr. O’Donnell was a partner and head of operations for Stanton & Bowery Hospitality Group, which owns 310 Bowery Bar, one of the top 10 bars in New York City, and has developed five additional concepts in the States of New York and Florida. From June 2009 to April 2015, Mr. O’Donnell was a senior underwriter for national accounts and private equity at ACE USA, which acquired and now operates as Chubb. Mr. O’Donnell is related by marriage to Mr. Schorsch, the chairman of our board of directors, and Mr. Schorsch, Jr., our president. Nicholas S. Schorsch, Jr. has been our President since December 2020. Mr. Schorsch, Jr. has spent over a decade in the real-estate, financial services, capital markets and M&A spaces as a member of the team at Bellevue Capital where he currently serves as the Chief Operating Officer of AR Global. Previously, he served as the Executive Vice President at AR Global and RCS. He has over 10 years of experience in acquisitions, asset management and capital markets for industry leading asset managers. During Mr. Schorsch, Jr.’s career, he has focused on acquisitions, operations and operational integration of individual assets, portfolios and enterprises, having helped source over $1 billion in real-estate acquisitions in multiple asset classes, served on the investment committee for a corporate credit fund focused on middle market companies with $2.6 billion in assets under management. Additionally, Mr. Schorsch, Jr. managed a team that raised over $10 billion in retail equity for various funds, participated in over $20 billion of corporate M&A transactions, helped build an integrated financial services platform with nearly 10,000 employees servicing 2.5 million accounts with almost $225 billion in assets under management. In his career, he has overseen diligence and acquisition of concepts for the platform in the brewing and distilling, hospitality and lodging, restaurants, consumer goods, entertainment and the automotive sectors. Mr. Schorsch, Jr. has also led Bellevue Capital’s technology initiatives to modernize its cloud infrastructure across its global operations and develop proprietary database systems to properly allocate platform costs among the subsidiaries of Bellevue Capital. Mr. Schorsch, Jr. is a graduate of Sarah Lawrence College, where he earned his Bachelor of Arts degree. Mr. Schorsch, Jr. is the son of Mr. Schorsch, the chairman of our board of directors. 109 TABLE OF CONTENTS Joseph Marnikovic has been our Chief Financial Officer and Treasurer since December 2020. Since January 2019, Mr. Marnikovic has served as the Chief Financial Officer of AR Global and Bellevue Capital. He has previously served as the Chief Accounting Officer of AR Global and Bellevue Capital from October 2017 until January 2019. Prior to joining AR Global, Mr. Marnikovic served in senior corporate officer roles for large regional organizations. At Carpionato Group, Mr. Marnikovic was the Chief Operating Officer and the Chief Financial Officer from January 2014 until August 2016, where he directed the finance department and led the property management and hospitality divisions. From December 2016 until September 2017, he was the Principal of Diamond Companies, a real estate development and management company. Prior to that, he was the Director of Accounting at Barkan Management, where he led the finance department and was a senior member of the management team in the firm’s client services group. Mr. Marnikovic was the Chief Operating Officer during a four-year tenure at MG2 Group, where he directed the property management and hospitality divisions, maintained back office support of Finance, Legal, Human Resources and Information Technology departments and vertically integrated Construction, Development, and Leasing into the company’s business model. Mr. Marnikovic also served in multiple capacities during his eight-year tenure as the Chief Financial Officer at Crosshaven Partners, where he led the real estate development arm and maintained financial control of the group’s portfolio companies in manufacturing of licensed merchandise and multi-unit franchising. He also held senior associate positions during a five-year public accounting career at PricewaterhouseCoopers LLP and O’Connor & Drew, P.C. Mr. Marnikovic has been a licensed CPA since 1998, a licensed Real Estate broker since 2007, and earned the CPM® designation from the Institute of Real Estate Management in 2013. Mr. Marnikovic received a bachelor degree in Accounting and a master degree in Finance from Boston College. Michael R. Anderson has been our General Counsel and Secretary since December 2020. Mr. Anderson joined AR Global in 2013 as assistant general counsel and has served as the Chief Corporate Counsel for Bellevue Capital and AR Global since February 2018. In his capacity as the Chief Corporate Counsel, Mr. Anderson has advised on both public and private debt and equity transactions, mergers and corporate acquisitions, commercial real estate transactions and operational integration of acquired companies. Mr. Anderson earned a Bachelor of Arts degree from the University of Arizona and a Juris Doctor degree from the University of Mississippi School of Law, where he graduated summa cum laude. Nicholas S. Schorsch has been a member of our board of directors since December 2020. He also serves as the chairman of the board of managers of Bellevue Capital. Mr. Schorsch has 43 years of investing experience and has acquired, sold or merged over 60 companies. Mr. Schorsch is a two-time winner of the Ernst & Young Entrepreneur of the Year award, first winning Entrepreneur of the Year in 2003 and subsequently receiving Ernst and Young’s Lifetime Achievement Award in 2011. He previously founded and served as the Chairman and Chief Executive Officer of ARCP, an investment services firm that he founded in 2010. After its initial public offering in 2011, Mr. Schorsch grew ARCP from a $65 million company to be the second-largest net-lease REIT in the United States, with over $20 billion of market capitalization. ARCP executed six significant mergers in 2013 and 2014 for a total of over $22 billion, including the acquisition of Cole Capital, the second largest sponsor of non-traded REITs at the time. He is the founder of RCS, a brokerage firm that was the industry’s leading multiproduct distributor of direct investment programs. Mr. Schorsch was also the founder of RCAP, a full-service financial services firm with an initial public offering in 2013. From 2013 to 2015, RCAP acquired nine independent broker dealers to assemble the second-largest independent broker dealer in the country at the time, with hundreds of billions of dollars in assets under management and thousands of registered financial professionals. RCAP also combined investment banking, research, legal, transfer agency, workflow, crowdfunding, events and marketing services into a single vertically integrated platform. He is also the founder and former President of Thermal Reduction Corporation, a metal product manufacturing business which he grew through expansion and a series of mergers and acquisitions that expanded product lines and rebranded the company before selling the business to Corrpro in 1994. Mr. Schorsch is the former President and former Chief Executive Officer of AFR, a publicly traded REIT that owned properties leased to financial institutions. Mr. Schorsch guided AFR from an initial $20 million real estate investment to an initial public offering in 2003. AFR was acquired by Gramercy Corp. in 2007 for $3.1 billion. In addition, Mr. Schorsch is the founder and managing member of AR Global, Metropolitan Wealth Management, LLC, ARC Real Estate Partners, LLC and Bellevue Capital. Mr. Schorsch has significant experience in numerous industries, including commercial real estate, manufacturing, hospitality, food and beverage and automobiles. In connection with his prior position as Chairman of the Board and Chief Executive Officer of each of American Realty Capital 110 TABLE OF CONTENTS Properties, Inc. (“ARCP”), American Realty Capital Trust III, Inc. (“ARCT III”) and American Realty Capital Trust IV, Inc. (“ARCT IV”), Mr. Schorsch, without admitting or denying any of the allegations made against him, reached a settlement with the SEC in connection with an investigation of certain disclosures in connection with the merger of ARCP and ARCT III in February 2013 and the merger of ARCP and ARCT IV in January 2014. As part of the settlement, entered into on July 16, 2019, the SEC did not allege any intentional misrepresentations or willful misconduct on the part of Mr. Schorsch; however, Mr. Schorsch (i) agreed to the entry of an order enjoining him from violating Sections 17(a)(2) and (a)(3) of the Securities Act and Rule 13b2-1 of the Exchange Act and (ii) agreed to pay a penalty in the amount of $7 million and to disgorge certain securities and monetary amounts with AR Capital on a joint-and-several basis. Edward M. Weil, Jr. is our director nominee. Mr. Weil has served as chairman of the board of directors and as chief executive officer and president of AFIN, the AFIN advisor and the AFIN property manager, since November 2015. Mr. Weil also previously served as an executive officer of AFIN, the AFIN advisor and the AFIN property manager from their formation in January 2013 until November 2014, and served as a director of AFIN from January 2013 to September 2014. Mr. Weil also has been the chief executive officer of AR Global since January 2016 and is a member of Bellevue Capital. Currently, he also serves in leadership positions at three other REITs advised by affiliates of AR Global: as a director of NYSE-listed GNL since January 2017; as executive chairman of NYCR since November 2015 and as chief executive officer, president and secretary of NYCR, the NYCR advisor and the NYCR property manager since March 2017; and as a director of Healthcare Trust, Inc. (“HTI”) since October 2016 and as chief executive officer of HTI, the HTI advisor and the HTI property manager since August 2018. Mr. Weil previously served in leadership positions at multiple REITs and other entities advised by affiliates of AR Global, including: as chairman, chief executive officer, president of American Realty Capital Healthcare Trust III, Inc. (“HT III”) until its liquidation and dissolution in March 2019; as executive chairman of American Realty Capital Global Trust II, Inc. (“Global II”) until December 2016, when Global II merged with GNL, as a director of Business Development Corporation of America (“BDCA”) until November 2016, when BDCA’s external advisor was acquired by Benefit Street Partners, L.L.C.; as chief executive officer, president and chairman of American Realty Capital  —  Retail Centers of America, Inc. (“RCA”) until its merger with AFIN in February 2017; as a trustee of American Real Estate Income Fund (“AREIF”) until its liquidation in August 2016; as a trustee of Realty Capital Income Funds Trust (“RCIFT”), a family of mutual funds, until its dissolution in January 2017; and as an executive officer and director of American Realty Capital Daily Net Asset Value Trust, Inc. during multiple periods until its dissolution and liquidation in April 2016. Mr. Weil also served as chairman of RCS from September 2013 until November 2015 and was the interim chief executive officer of RCS from May 2014 until September 2014 and the chief executive officer of RCS from December 2010 until September 2013. Mr. Weil served as a director of RCAP, the parent company of RCS, from February 2013 until December 2015 and served as an executive officer of RCAP from February 2013 until November 2015, including chief executive officer from September 2014 until November 2015. RCAP filed for Chapter 11 bankruptcy in January 2016. Mr. Weil was formerly the senior vice president of sales and leasing for AFR, where he was responsible for the disposition and leasing activity for a 33 million square foot portfolio of properties. Mr. Weil also previously served on the board of directors of the Real Estate Investment Securities Association (now known as ADISA) from 2012 to 2014, including as its president in 2013. Leslie D. Michelson is our director nominee. Mr. Michelson served as the chief executive officer, chairman and director from April 2007 until February 2020 and as the executive chairman and director beginning in March 2020 of Private Health Management, a company which assists corporate employees and their dependents, families and individuals in obtaining the best medical care. Mr. Michelson has served as an independent director of BDCA, an entity which was previously advised by an affiliate of AR Global, since January 2011, including as lead independent director since February 2016. In November 2016, BDCA’s external advisor was acquired by Benefit Street Partners, L.L.C. Mr. Michelson has served as an independent director of HTI since December 2015, including as non-executive chair since October 2016. Mr. Michelson has served as an independent director of AFIN since February 2017. In addition, Mr. Michelson has served as an independent director of Franklin BSP Capital Corporation since March 2020. Mr. Michelson previously served as an independent director of RCA from November 2015 until its merger with AFIN in February 2017 and previously served as an independent director of RCA from 111 TABLE OF CONTENTS March 2012 until October 2012. Mr. Michelson previously served as an independent director of Business Development Corporation of America II (“BDCA II”) from August 2014 until its liquidation and dissolution in September 2016 and as an independent trustee of RCIFT, a family of mutual funds advised by an affiliate of AR Global, from April 2013 until its dissolution in January 2017. Mr. Michelson previously served as an independent director of American Realty Capital Healthcare Trust, Inc. (“HT”) from January 2011 until July 2012 and as lead independent director of HT from July 2012 until January 2015 when HT closed its merger with Ventas, Inc. Mr. Michelson served as an independent director of American Realty Capital Trust, Inc. from January 2008, including as lead independent director from July 2012, until its merger with Realty Income Corporation in January 2013. Mr. Michelson also served as an independent director of VEREIT, Inc. (“VEREIT”) from October 2012 until April 2015. Mr. Michelson also served as an independent director of BDCA Venture, Inc. from June 2014 until June 2015. Mr. Michelson served as lead independent director of Benefit Street Partners Realty Trust, Inc. (formerly known as Realty Finance Trust, Inc.) from January 2013 until November 2014. Mr. Michelson served as an independent director of American Realty Capital Daily Net Asset Value Trust, Inc. (“DNAV”) from August 2011 until February 2012 and as an independent director of New York REIT, Inc. (“NYRT”) from October 2009 until August 2011. Mr. Michelson has served as a member of the Board of Advisors of the UCLA Fielding School of Public Health since October 2013. He has served as a director of Druggability Technology Holdings, Ltd., a proprietary pharmaceutical product business dedicated to the development and commercialization of high-value pharmaceutical products, since April 2013. He has served as founder and chief executive officer as well as a director of Michelson on Medicine, LLC since January 2011. Mr. Michelson served as vice chairman and chief executive officer of the Prostate Cancer Foundation, the world’s largest private source of prostate cancer research funding, from 2002 until 2006 and served on its board of directors from 2002 until 2013. Mr. Michelson served on the Board of Directors of Catellus Development Corp. (“Catellus”), from 1997 until 2004 when the company was sold to ProLogis. Mr. Michelson was a member of the Audit Committee of the Board of Directors of Catellus for five years and served at various times as the chairman of the Audit Committee and the Compensation Committee. From 2001 to 2002, he was an investor in, and served as an advisor or director of, a portfolio of entrepreneurial healthcare, technology and real estate companies. From 2000 to 2001, he served as chief executive officer and as a director of Acurian, Inc., an Internet company that accelerates clinical trials for new prescription drugs. From 1998 to 1999, Mr. Michelson served as chairman and co-chief executive officer of Protocare, Inc., a manager of clinical trials for the pharmaceutical industry and disease management firm. From 1988 to 1998, he served as chairman and chief executive officer of Value Health Sciences, Inc., an applied health services research firm he co-founded. Mr. Michelson served as a director of Nastech Pharmaceutical Company Inc., a NASDAQ-traded biotechnology company focused on innovative drug delivery technology, from 2004 to 2008, of Highlands Acquisition Company, an AMEX-traded special purpose acquisition company, from 2007 to 2009, of G&L Realty Corp., a NYSE-traded medical office building REIT from 1995 to 2001, and of Landmark Imaging, a privately held diagnostic imaging and treatment company, from 2007 to 2010. Also since 2004, he has served as a director of ALS-TDI, a philanthropy dedicated to curing Amyotrophic Lateral Sclerosis, commonly known as Lou Gehrig’s disease. Mr. Michelson received his B.A. from The Johns Hopkins University in 1973 and a J.D. from Yale Law School in 1976. M. Therese Antone is our director nominee. M. Therese Antone is the Chancellor of Salve Regina University, where she previously served as the President from 1994 to 2009 and the Executive Vice President for Corporate Affairs and Advanceme